소프트젤 캡슐 시장 : 시장 규모, 점유율, 성장, 업계 분석, 지역별 동향 및 예측(2026-2034년)

Growth Factors of softgel capsules Market

The global softgel capsules market is experiencing robust growth, driven by increasing demand for nutraceuticals, dietary supplements, and advanced pharmaceutical dosage forms. Softgel capsules are widely used for delivering vitamins, omega-3 oils, herbal extracts, specialty ingredients, and pharmaceutical formulations due to their ease of swallowing, improved stability, and enhanced bioavailability. Rising consumer awareness regarding preventive healthcare and wellness products is further supporting market expansion worldwide.

Market Size and Market Value

The global softgel capsules market was valued at USD 7.87 billion in 2025. The market is expected to grow to USD 8.32 billion in 2026 and is projected to reach USD 13.46 billion by 2034, reflecting strong long-term demand from pharmaceutical, nutraceutical, and cosmetic industries.

North America dominated the market in 2025, accounting for 35.58% of global revenue due to its well-established dietary supplement industry and strong pharmaceutical manufacturing base.

Market Trends

A major trend shaping the market is the growing use of softgel capsules to improve the bioavailability of active ingredients. Many pharmaceutical and nutraceutical compounds have poor water solubility, limiting absorption. Softgel technologies help overcome this challenge by delivering ingredients in lipid-based or pre-dissolved forms.

In March 2026, Sirio Europe introduced Life Chews, a plant-based chewable delivery technology designed for lipid-soluble active ingredients, highlighting ongoing innovation in softgel-based delivery systems.

Market Drivers

Rising Consumption of Nutraceuticals and Dietary Supplements

Growing consumer interest in preventive healthcare is significantly increasing demand for vitamins, omega-3 supplements, immunity boosters, and herbal products. Softgel capsules are highly preferred because they are convenient, easy to swallow, and suitable for liquid or oil-based ingredients.

In October 2025, Caldic and Lonza Capsugel entered an exclusive North American partnership to expand nutraceutical applications, demonstrating the growing commercial importance of softgel formulations.

Market Restraints

Quality Control and Stability Challenges

Softgel capsules require strict control over shell composition, fill formulation, and storage conditions. Manufacturers often face challenges such as leakage, shell deformation, cross-linking, and dissolution issues, particularly in high-temperature and humid environments.

These concerns increase production costs and require extensive stability testing, limiting market growth to some extent.

Market Opportunities

Growing Demand for Plant-Based Softgel Capsules

The increasing popularity of vegan and plant-based lifestyles is creating new opportunities for non-animal softgel capsules. Consumers are seeking alternatives to gelatin-based products due to ethical, dietary, and religious preferences.

Manufacturers are responding by investing in starch-based, pullulan-based, and other plant-derived softgel technologies that provide similar performance and stability while meeting consumer demands.

Market Challenges

Rising Raw Material and Manufacturing Costs

Softgel manufacturing depends heavily on gelatin and specialty ingredients, making the industry vulnerable to supply-chain disruptions and raw-material price fluctuations. In addition, softgel production requires sophisticated manufacturing equipment and strict environmental controls, increasing operational costs.

These factors continue to pressure profit margins and present challenges for manufacturers globally.

Segment Analysis

By Type

The gelatin capsules segment dominated the market in 2025 due to its widespread acceptance, manufacturing efficiency, and compatibility with various formulations. Meanwhile, the non-animal softgel segment is expected to witness the fastest growth as demand for vegan products rises.

By Application

The prescription medicines segment held the largest market share because pharmaceutical companies increasingly use softgels to improve drug absorption, patient compliance, and product differentiation.

By Manufacturers

Pharmaceutical companies accounted for the largest market share due to their extensive product portfolios, regulatory expertise, and investments in advanced drug-delivery technologies.

Regional Analysis

North America

North America generated USD 2.80 billion in 2025, maintaining its position as the largest regional market. High dietary supplement consumption and advanced healthcare infrastructure continue to support regional growth.

Europe

Europe is witnessing strong demand due to its aging population and growing consumption of preventive healthcare products, vitamins, and wellness supplements.

Asia Pacific

Asia Pacific is expected to emerge as one of the fastest-growing regions, supported by increasing disposable income, urbanization, and rising awareness of nutritional supplementation.

Latin America and Middle East & Africa

These regions are experiencing gradual growth due to expanding healthcare access and increasing consumer spending on wellness and nutritional products.

Competitive Landscape

Major companies operating in the softgel capsules market include:

• Lonza
• Sirio Pharma
• Catalent Inc.
• Hunan Er Kang Pharmaceutical Co., Ltd
• Aenova Group GmbH

These companies are focusing on capacity expansion, technological innovation, strategic partnerships, and plant-based capsule development to strengthen their market positions.

Conclusion

The global softgel capsules market is positioned for significant growth, supported by rising demand for nutraceuticals, pharmaceuticals, and preventive healthcare products. The market is projected to expand from USD 7.87 billion in 2025 to USD 8.32 billion in 2026, reaching USD 13.46 billion by 2034. Increasing adoption of bioavailability-enhancing formulations, growing demand for plant-based capsules, and continuous innovation in drug delivery technologies will remain key growth drivers. Despite challenges related to manufacturing complexity and raw-material costs, expanding applications across healthcare and wellness industries are expected to create substantial opportunities for market participants throughout the forecast period.

Segmentation By Type, Application, Manufacturers, and Region

By Type * Gelatin Capsules

• Non-Animal Softgel Capsules
  • Starches
  • Pullulan
  • Others
• Prescription Medicines
• OTC
• Nutraceutical
• Pharmaceutical Companies
• Nutraceutical Companies
• Others

By Application * Prescription Medicines

• OTC
• Nutraceutical

By Manufacturers

• Pharmaceutical Companies
• Nutraceutical Companies
• Others

By Region * North America (By Type, Application, Manufacturers, and Country)

• U.S.
• Canada
• Europe (By Type, Application, Manufacturers, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Type, Application, Manufacturers, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, Application, Manufacturers, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Application, Manufacturers, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. New Product Launches, By Key Players
• 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, among others.)
• 4.3. Regulatory Scenario, By Key Countries/Regions
• 4.4. Overview: Emerging Application Areas of Softgel Capsules

5. Global Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Gelatin Capsules
  • 5.1.2. Non Animal Softgel Capsules
    • 5.1.2.1. Starches
    • 5.1.2.2. Pullulan
    • 5.1.2.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Prescription Medicines
  • 5.2.2. OTC
  • 5.2.3. Nutraceutical
• 5.3. Market Analysis, Insights and Forecast - By Manufacturers
  • 5.3.1. Pharmaceutical Companies
  • 5.3.2. Nutraceutical Companies
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Gelatin Capsules
  • 6.1.2. Non Animal Softgel Capsules
    • 6.1.2.1. Starches
    • 6.1.2.2. Pullulan
    • 6.1.2.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Prescription Medicines
  • 6.2.2. OTC
  • 6.2.3. Nutraceutical
• 6.3. Market Analysis, Insights and Forecast - By Manufacturers
  • 6.3.1. Pharmaceutical Companies
  • 6.3.2. Nutraceutical Companies
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Gelatin Capsules
  • 7.1.2. Non Animal Softgel Capsules
    • 7.1.2.1. Starches
    • 7.1.2.2. Pullulan
    • 7.1.2.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Prescription Medicines
  • 7.2.2. OTC
  • 7.2.3. Nutraceutical
• 7.3. Market Analysis, Insights and Forecast - By Manufacturers
  • 7.3.1. Pharmaceutical Companies
  • 7.3.2. Nutraceutical Companies
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Gelatin Capsules
  • 8.1.2. Non Animal Softgel Capsules
    • 8.1.2.1. Starches
    • 8.1.2.2. Pullulan
    • 8.1.2.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Prescription Medicines
  • 8.2.2. OTC
  • 8.2.3. Nutraceutical
• 8.3. Market Analysis, Insights and Forecast - By Manufacturers
  • 8.3.1. Pharmaceutical Companies
  • 8.3.2. Nutraceutical Companies
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. India
  • 8.4.4. Southeast Asia
  • 8.4.5. Australia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Gelatin Capsules
  • 9.1.2. Non Animal Softgel Capsules
    • 9.1.2.1. Starches
    • 9.1.2.2. Pullulan
    • 9.1.2.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Prescription Medicines
  • 9.2.2. OTC
  • 9.2.3. Nutraceutical
• 9.3. Market Analysis, Insights and Forecast - By Manufacturers
  • 9.3.1. Pharmaceutical Companies
  • 9.3.2. Nutraceutical Companies
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Gelatin Capsules
  • 10.1.2. Non Animal Softgel Capsules
    • 10.1.2.1. Starches
    • 10.1.2.2. Pullulan
    • 10.1.2.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Prescription Medicines
  • 10.2.2. OTC
  • 10.2.3. Nutraceutical
• 10.3. Market Analysis, Insights and Forecast - By Manufacturers
  • 10.3.1. Pharmaceutical Companies
  • 10.3.2. Nutraceutical Companies
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of the Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Capsugel (Lonza)
  • 11.2.2. Sirio Pharma
  • 11.2.3. Catalent Inc.
  • 11.2.4. Hunan Er Kang Pharmaceutical Co., Ltd
  • 11.2.5. Aenova Group GmbH
  • 11.2.6. Fuji Capsule Co., Ltd.
  • 11.2.7. Captek Softgel International Inc.
  • 11.2.8. Curtis Health Caps S.A.
  • 11.2.9. EuroCaps Ltd
  • 11.2.10. ALCALA FARMA laboratories (SYNERLAB)
  • 11.2.11. Cloverty.